Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model
about
sameAs
Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strainsCefditoren in upper and lower community-acquired respiratory tract infectionsPoor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody TitersUpdate on the clinical utility and optimal use of cefditorenFosfomycin enhances phagocyte-mediated killing of Staphylococcus aureus by extracellular traps and reactive oxygen species.Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adultsBactericidal synergism between antibiotics and phage endolysin Cpl-711 to kill multidrug-resistant pneumococcus
P2860
Q34408016-9CDEF754-13F0-4D9B-ABC0-DBED4D620362Q34574090-6D66FE70-E015-4114-8226-8B874DDDBCCAQ35933953-3553BBF1-2023-42FF-8A55-3AA2617F91B3Q36008860-E6F5E7F8-81FF-414E-A397-96B4094C6EA1Q36499980-BE4FD490-72C2-4080-9728-C7EF3E8623E1Q41570386-60B25324-F3F3-42C7-935A-5E41D10D1358Q58617498-2DDB5F28-0CC1-4818-84AC-72AD78BD3E38Q58703020-11B69D30-6398-4C4E-A981-3A0BDFB8FBBC
P2860
Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@ast
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@en
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@nl
type
label
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@ast
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@en
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@nl
prefLabel
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@ast
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@en
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@nl
P2093
P2860
P50
P1433
P1476
Enhanced in vivo activity of c ...... 19F and 23F) in a sepsis model
@en
P2093
David Sevillano
Elisa Ramos-Sevillano
Ernesto García
Fabio Cafini
Jose Prieto
Lorenzo Aguilar
Martha Torrico
Natalia González
Pilar Coronel
P2860
P304
P356
10.1371/JOURNAL.PONE.0012041
P407
P577
2010-08-10T00:00:00Z